1,000 volunteers injected with the home-grown vaccine Nanocovax in third-phase trials have developed antibodies against COVID-19, according to a report by Nanogen Pharmaceutical Biotechnology JSC, the vaccine producer. The report…
Read More1,000 volunteers injected with the home-grown vaccine Nanocovax in third-phase trials have developed antibodies against COVID-19, according to a report by Nanogen Pharmaceutical Biotechnology JSC, the vaccine producer. The report…
Read MorePage 1 of 1